Gene Therapy in Treating Patients With Recurrent Malignant Gliomas

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

February 25, 1999

Primary Completion Date

July 22, 2002

Study Completion Date

July 1, 2003

Conditions
Brain and Central Nervous System Tumors
Interventions
BIOLOGICAL

Ad5CMV-p53 gene

PROCEDURE

conventional surgery

Trial Locations (8)

15213

University of Pittsburgh Cancer Institute, Pittsburgh

53792

University of Wisconsin Comprehensive Cancer Center, Madison

77030

University of Texas - MD Anderson Cancer Center, Houston

94115-0128

UCSF Cancer Center and Cancer Research Institute, San Francisco

02115

Dana-Farber Cancer Institute, Boston

48109-0752

University of Michigan Comprehensive Cancer Center, Ann Arbor

75235-9154

Simmons Cancer Center - Dallas, Dallas

78284-7811

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00004041 - Gene Therapy in Treating Patients With Recurrent Malignant Gliomas | Biotech Hunter | Biotech Hunter